Overview


According to FutureWise analysis the market for Digital Subtraction Angiography in 2023 is US$ 0.42 billion, and is expected to reach US$ 0.73 billion by 2031 at a CAGR of 7.20%.

A digital subtraction angiography (DSA) is an imaging technique used to diagnose vascular disorders using radiographic images or fluoroscopic images. A blood vessel can also be visualized in a dense soft tissue environment or a bone using this technique. The DSA technique is used to obtain clear images of the arteries, as well as to contrast arterial structures with the surrounding bone and tissue. Digital subtraction angiography has proven to be effective in detecting abnormalities such as ulcerated plaques, stenosis, occlusions, and aneurysms. Furthermore, DSA is widely used as a tool to assess vascular by-pass grafts, aortic arch anomalies, and aortic contraction in addition to carotid arteries. The technique is being replaced by computed tomography angiography (CTA), which is a less invasive test that produces 3D images. Newly developed three-dimensional DSA has proven to be superior to two-dimensional DSA in the detection and delineation of intracranial aneurysms, with lower radiation dose, less contrast, and shorter procedure time.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Digital Subtraction Angiography Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Digital Subtraction Angiography Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • GE Healthcare
  • Siemens AG
  • Phillips Healthcare
  • Toshiba Corporation
  • Medtronic, Inc.
  • Boston Scientific Corporation
  • Abbott Vascular
  • St. Jude Medical
  • Shimazdu Corporation
  • Cordis Corporation
  • DMS Group
  • Eigen LLC.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product Type

  • Instruments
  • Contrast Medium

By Technology

  • Traditional Imagining Technology
  • Noise Reduction Imagining Technology

By Procedure

  • Intra-Arterial Digital Subtraction Angiography
  • Intravenous Digital Subtraction Angiography

By Indication

  • Carotid Artery Disorders
  • Thoracic Vascular Disorders
  • Abdominal Aorta Disorders
  • Intracranial Aorta Disorders
  • Pulmonary Aorta Disorders
  • Peripheral Aorta Disorders
  • Renal Aorta Disorders
  • Extracranial Carotid Occlusive Disorders
  • Others

By End User

  • Medium-sized and Large Hospitals
  • Diagnostic Centers
  • Outpatient Clinics
  • Laboratories in Universities

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Digital Subtraction Angiography Market By Product Type, By Technology, By Procedure, By Indication, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Digital Subtraction Angiography Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Digital Subtraction Angiography Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Digital Subtraction Angiography Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Digital Subtraction Angiography Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Instruments
        2. Contrast Medium

  • 8.   Digital Subtraction Angiography Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Traditional Imagining Technology
        2. Noise Reduction Imagining Technology

  • 9.   Digital Subtraction Angiography Market, By Procedure Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Intra-Arterial Digital Subtraction Angiography
        2. Intravenous Digital Subtraction Angiography

  • 10.   Digital Subtraction Angiography Market, By Indications Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Carotid Artery Disorders
        2. Thoracic Vascular Disorders
        3. Abdominal Aorta Disorders
        4. Intracranial Aorta Disorders
        5. Pulmonary Aorta Disorders
        6. Peripheral Aorta Disorders
        7. Renal Aorta Disorders
        8. Extracranial Carotid Occlusive Disorders
        9. Others

  • 11.   Digital Subtraction Angiography Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Medium-sized and Large Hospitals
        2. Diagnostic Centers
        3. Outpatient Clinics
        4. Laboratories in Universities

  • 12.   North America Digital Subtraction Angiography Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 13.   Latin America Digital Subtraction Angiography Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 14.   Europe Digital Subtraction Angiography Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 15.   Asia Pacific Digital Subtraction Angiography Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 16.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 17.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. GE Healthcare
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Siemens AG
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Phillips Healthcare
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Toshiba Corporation
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Medtronic, Inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Boston Scientific Corporation
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Abbott Vascular
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. St. Jude Medical
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Shimazdu Corporation
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.Cordis Corporation
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11.DMS Group
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12.Eigen LLC.
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview

  • 19.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 20.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients